Pregabalin reduces alcohol drinking and relapse to alcohol seeking in the rat

Psychopharmacology

Volumn 220, Issue 1, 2012, Pages 87-96

  Stopponi, Serena ^a   Somaini, Lorenzo ^b   Cippitelli, Andrea ^a   De Guglielmo, Giordano ^a   Kallupi, Marsida ^a   Cannella, Nazzareno ^a   Gerra, Gilberto ^c   Massi, Maurizio ^a   Ciccocioppo, Roberto ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b OSPEDALE DEGLI INFERMI   (Italy)

^c United Nations Office on Drugs and Crime Austria   (Austria)

Author keywords

Addiction; Alcohol drinking; Alcoholism; GABA; Relapse

Indexed keywords

PREGABALIN; YOHIMBINE;

ALCOHOL ABUSE; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SCREENING; ENVIRONMENTAL STRESS; INSTRUMENTAL CONDITIONING; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE;

ALCOHOL DRINKING; ANIMALS; ANTICONVULSANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; ETHANOL; GAMMA-AMINOBUTYRIC ACID; MALE; RATS; RECURRENCE; SELECTION, GENETIC; SELF ADMINISTRATION; YOHIMBINE;

EID: 84858441443     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2457-3     Document Type: Article

References (62)

1. Abercrombie ED, Keller RW Jr, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by micro-dialysis perfusion: pharmacological and behavioral studies. Neuroscience 27:897-904 (Pubitemid 19025396)
2. Addolorato G, Leggio L (2010) Pregabalin similar to lorazepam for alcohol withdrawal symptoms. Evid Based Med 15:73
3. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002a) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol 37:504-508
4. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002b) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112:226-229
5. Aghajanian GK, VanderMaelen CP (1982) Alpha 2-adrenoceptorme-diated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215:1394-1396 (Pubitemid 12129720)
6. Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA (2005) Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64:475-480 (Pubitemid 40189866)
7. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (2010) A comparison of the pharmacokinetics and pharmacody-namics of pregabalin and gabapentin. Clin Pharmacokinet 49:661-669
8. Bonnet U, Banger M, Leweke FM, Maschke M, Kowalski T, Gastpar M (1999) Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry 32:107-109 (Pubitemid 29364444)
9. Bonnet U, Specka M, Leweke FM, Nyhuis P, Banger M (2007) Gabapentin's acute effect on mood profile: a controlled study on patients with alcohol withdrawal. Prog Neuropsychopharmacology Biol Psychiatry 31:434-438 (Pubitemid 46209439)
10. Book SW, Myrick H (2005) Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs 14:371-376 (Pubitemid 40711848)
11. Bozikas V, Petrikis P, Gamvrula K, Savvidou I, Karavatos A (2002) Treatment of alcohol withdrawal with gabapentin. Prog Neuro-psychopharmacology Biol Psychiatry 26:197-199 (Pubitemid 34045168)
12. Bryans JS, Wustrow DJ (1999) 3-Substituted GABA analogs with central nervous system activity: a review. Med Res Rev 19:149-177 (Pubitemid 29124983)
13. Canti C, Davies A, Dolphin AC (2003) Calcium channel α2δ subunits: structure, functions and target site for drugs. Curr Neuropharmacol 1:209-217
14. Charney DS, Heninger GR, Redmond DE Jr (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33:19-29 (Pubitemid 13055358)
15. Ciccocioppo R, Martin-Fardon R, Weiss F (2002) Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27:391-399 (Pubitemid 35256145)
16. Ciccocioppo R, Economidou D, Cippitelli A, Cucculelli M, Ubaldi M, Soverchia L, Lourdusamy A, Massi M (2006) Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol 11:339-355 (Pubitemid 46696907)
17. Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R (2008) Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology (Berl) 198:449-460
18. Colombo G, Vacca G, Serra S, Brunetti G, Carai MA, Gessa GL (2003) Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl) 167:221-224 (Pubitemid 36712968)
19. Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, Jones RS (2004) Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 20:1566-1576 (Pubitemid 39294695)
20. Di Nicola M, Martinotti G, Tedeschi D, Frustaci A, Mazza M, Sarchiapone M, Pozzi G, Bria P, Janiri L (2010) Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol 25:268-275
21. Dooley DJ, Donovan CM, Pugsley TA (2000a) Stimulus-dependent modulation of [(3H)]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 296:1086-1098
22. Dooley DJ, Mieske CA, Borosky SA (2000b) Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 280:107-110 (Pubitemid 30109144)
23. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274-1283 (Pubitemid 36460982)
24. Economidou D, Fedeli A, Fardon RM, Weiss F, Massi M, Ciccocioppo R (2006) Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27:3299-3306 (Pubitemid 44738195)
25. Engel JAC, Fahlke C, Hard E, Johannessen K, Svensson L, Soderpalm B (1992) Serotonergic and dopaminergic involvement in ethanol intake. Clin Neuropharmacol 15:64A-65A
26. Fehrenbacher JC, Taylor CP, Vasko MR (2003) Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 105:133-144
27. Field MJ, Oles RJ, Singh L (2001) Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity. Br J Pharmacol 132:1-4 (Pubitemid 32128426)
28. Fink K, Meder W, Dooley DJ, Gothert M (2000) Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 130:900-906 (Pubitemid 30389071)
29. Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, Gothert M (2002) Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42:229-236 (Pubitemid 34137026)
30. Gehlert DR, Cippitelli A, Thorsell A, Lê AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2, 6-dimethyl-imidazo[1,2-b] pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27 (10):2718-2726 (Pubitemid 46393604)
31. Gentry JR, Hill C, Malcolm R (2002) New anticonvulsants: a review of applications for the management of substance abuse disorders. Ann Clin Psychiatry 14:233-245 (Pubitemid 36231916)
32. Grobin AC, Matthews DB, Devaud LL, Morrow AL (1998) The role of GABA A receptors in the acute and chronic effects of ethanol. Psychopharmacology 139:2-19 (Pubitemid 28416878)
33. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Björk K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci USA 103:15236-15241 (Pubitemid 44583194)
34. Heilig M, Koob GF (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30:399-406 (Pubitemid 47090230)
35. Holberg G, Gershon S, Beck LH (1962) Yohimbine as an autonomic test drug. Nature 193:1313-1314
36. Hyytia P, Koob GF (1995) GABAA receptor antagonism in the extended amygdala decreases ethanol self administration in rats. Eur J Pharmacol 283:151-159
37. Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharma-cology (Berl) 179:366-373
38. Lee B, Tiefenbacher S, Platt DM, Spealman RD (2004) Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsycho-pharmacology 29:686-693 (Pubitemid 38402476)
39. Lesser H, Sharma U, LaMareaux L, Poole RM (2004) Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 63:2104-2110 (Pubitemid 39636259)
40. Li CY, Zhang XL, Matthews EA, Li KW, Kurwa A, Boroujerdi A, Gross J, Gold MS, Dickenson AH, Feng G, Luo ZD (2006) Calcium channel alpha2delta1 subunit mediates spinal hyperex-citability in pain modulation. Pain 125:20-34 (Pubitemid 44498959)
41. Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP (2006) A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict 15:76-84 (Pubitemid 43207192)
42. Marinelli PW, Funk D, Juzytsch W, Li Z, Lê AD (2007) Effects of opioid receptor blockade on the renewal of alcohol seeking induced by context: relationship to c-fos mRNA expression. Eur J Neurosci 26:2815-2823 (Pubitemid 350115512)
43. Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P (2008) Efficacy and safety of pregabalin in alcohol dependence. Adv Ther 25:608-618
44. Martinotti G, Di Nicola M, Tedeschi D, Andreoli S, Reina D, Pomponi M, Mazza M, Romanelli R, Moroni N, De Filippis R, Di Giannantonio M, Pozzi G, Bria P, Janiri L (2010) Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. J Psychopharmacol 24:1367-1374
45. Marwaha J, Aghajanian GK (1982) Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther 222:287-293 (Pubitemid 12047253)
46. Mason BJ, Light JM, Williams LD, Drobes DJ (2009) Clinical study: proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol 14:73-83
47. Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM, Goddard P, Abrams DB (1993) Cue exposure with coping skills treatment for male alcoholics: a preliminary investigation. J Consult Clin Psychol 61:1011-1019 (Pubitemid 24006591)
48. Myrick H, Anton R, Voronin K, Wang W, Henderson S (2007) A double blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res 31:221-227 (Pubitemid 46155221)
49. O'Brien CP, Childress AR, Ehrman R, Robbins SJ (1988) Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacology 12:15-22
50. Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, Londborg PD, Bielski RJ, Zimbroff DL, Davidson JR, Liu-Dumaw M (2003) Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160:533-540 (Pubitemid 41094262)
51. Pande AC, Feltner DE, Jefferson JW, Davidson JR, Pollack M, Stein MB, Lydiard RB, Futterer R, Robinson P, Slomkowski M, DuBoff E, Phelps M, Janney CA, Werth JL (2004) Efficacy of the novel anxiolytic pregabalin in social anxiety disorder-a placebo-controlled, multicenter study. J Clin Psychopharmacology 24:141-149 (Pubitemid 38380837)
52. Richter RW, Portenoy R, Sharma U, Lamareaux L, Bockbrader H, Knapp LE (2005) Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6:253-260 (Pubitemid 40488803)
53. Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC (2005) Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pre-gabalin and alprazolam. Arch Gen Psychiatry 62:1022-1030 (Pubitemid 41248382)
54. Roberto M, Gilpin NW, O'Dell LE, Cruz MT, Morse AC, Siggins GR, Koob GF (2008) Cellular and behavioral interactions of gabapentin with alcohol dependence. J Neurosci 28:5762-5771
55. Rosenstock J, Tuchman M, LaMareaux L, Sharma U (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638 (Pubitemid 39036794)
56. Schlicker E, Reimann W, Gothert M (1985) Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneim Forsch Drug Res 35:1347-1349 (Pubitemid 15230639)
57. Stahl SM (2004) Anticonvulsants as anxiolytics. Part 2: Pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels. J Clin Psychiatry 65:460-461
58. Taylor CP (1999) Mechanisms of new antiepileptic drugs. Adv Neurol 79:1011-1026
59. Voris J, Smith NL, Rao SM, Thorne DL, Flowers QJ (2003) Gabapentin for the treatment of ethanol withdrawal. Subst Abus 24:129-132 (Pubitemid 37087322)
60. Walker BM, Koob GF (2007) The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol Clin Exp Res 31(1):11-18 (Pubitemid 46025360)
61. Wang M, Offord J, Oxender DL, Su TZ (1999) Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding. Biochem J 342:313-320 (Pubitemid 29425352)
62. Watson WP, Robinson E, Little HJ (1997) The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome. Neuropharmacology 36:1369-1375 (Pubitemid 27502194)